Nano Computing - Impact Factor
Nanocomputing is a term used for the representation and manipulation of data by computers smaller than a microcomputer. Current devices are already utilizing transistors with channels below 100 nanometers in length. The current goal is to produce computers smaller than 10 nanometers. Future developments in
nanocomputing will provide resolutions to the current difficulties of forming computing technology at the nanoscale. For example, current nanosized transistors have been found to produce a quantum tunneling effect where electrons ‘tunnel’ through barriers, making them unsuitable for use as a standard switch.
Nanocomputing can be produced by a number of nanoscale structures including
biomolecules such as DNA and proteins. As DNA functions through a coding system of four nucleobases it is suited for application in data processing. DNA nanocomputers could produce faster problem solving through the ability to explore all potential solutions simultaneously. This is in contrast to conventional computers which solve problems by exploring solution paths one at a time in a series of steps. Practical applications of this theoretical technology will require the ability to control and program DNA flexibly. The earliest applications of DNA to computing will likely be in the form of transistor switches, kv
High Impact List of Articles
-
Uveitic macular edema: a stepladder treatment paradigm
Janine M Preble, Charles Stephen Foster
Clinical Trail Outcomes: Clinical Investigation
-
Uveitic macular edema: a stepladder treatment paradigm
Janine M Preble, Charles Stephen Foster
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
Antibody drug conjugates in lymphoma
Nitya Nathwani & Robert Chen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Antibody drug conjugates in lymphoma
Nitya Nathwani & Robert Chen
Review: Clinical Trail Outcomes: Clinical Investigation
-
Certolizumab pegol in the treatment of Crohns disease: evidence from the PRECiSE clinical trial program
Ian C Lawrance
Review Article: Clinical Investigation
-
Certolizumab pegol in the treatment of Crohns disease: evidence from the PRECiSE clinical trial program
Ian C Lawrance
Review Article: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
Relevant Topics in Clinical